Cimarron Healthcare Capital

What Cimarron Healthcare Capital does

Cimarron Healthcare Capital is a Salt Lake City-based private equity firm that invests exclusively in the healthcare industry, targeting lower-middle-market companies with $10-100M in revenue, up to $10M in EBITDA, and up to $30M in equity per transaction. The firm partners with founder-owned and family-controlled healthcare businesses and executes leveraged buyouts, growth buyouts, and team-first build-outs, typically requiring significant owner rollover to align incentives. Cimarron emphasizes 100% sector specialization and a value-add partnership model that supplies portfolio companies with capital, operating talent, and strategic guidance to transform sub-scale businesses into premium platforms.

The firm's active portfolio spans seven healthcare subsectors: AMPS (healthcare pricing technology and pharmacy benefit management, including the ClaimInsight, PriceDynamix, and Drexi product lines), Ascent Behavioral Health (adolescent mental health programs including the Oasis Ascent de novo program), Elite Anesthesia (outsourced anesthesia and perioperative care for dental and oral surgery clinics, recapitalized in 2024), Forward Health (sleep medicine roll-up with multiple acquisitions completed between 2023 and 2025), Frontpoint Health (home health and hospice for seniors, including the High Plains Senior Care acquisition in 2024), Infusion for Health (ambulatory infusion therapy, which reached 50 centers in May 2025), and PetVet365 (de novo veterinary hospital network).

Cimarron generates revenue through conventional private equity mechanics — management fees and carried interest on its investment funds, supplemented by capital appreciation and realized gains from portfolio exits — and sources deals primarily through a relationship-based network anchored by its healthcare-specialized senior team and operating partners with backgrounds at DaVita, Optum, Banfield Pet Hospital, UnitedHealthcare, McKinsey, Genstar Capital, and other healthcare institutions. The firm itself operates with 1-10 employees from its Salt Lake City headquarters.

Name

Cimarron Healthcare Capital

Legal name

Cimarron Healthcare Capital

Website

https://cimarronhc.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Cimarron Healthcare Capital is a Salt Lake City-based private equity firm that invests exclusively in lower-middle-market healthcare companies, executing leveraged buyouts, growth buyouts, and team-first build-outs alongside founder-owners across diverse healthcare subsectors.

Ownership category

akta.pro rank

Headquarters

HQ city

Salt Lake City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel

Revenue model

1. Private Equity Investment Returns: As a private equity firm, Cimarron generates returns through capital appreciation of portfolio companies, realized gains from exits, and potentially management fees or carried interest from their investment funds.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

No source data was provided to describe the company's core offering.

Product overview

Cimarron Healthcare Capital is a private equity firm that does not offer a single unified product, but rather maintains a portfolio of healthcare portfolio companies. The portfolio includes AMPS (Advanced Medical Pricing Solutions) which offers SaaS products including ClaimInsight, PriceDynamix, and Drexi for payment integrity and pharmacy benefit management; Ascent Behavioral Health with its Oasis Ascent program for adolescent mental health; Elite Anesthesia for outsourced anesthesia services; Forward Health for sleep disorder diagnosis and treatment; Frontpoint Health for home-based senior care; Infusion for Health for infusion therapy services; and PetVet365 for veterinary hospitals. Each portfolio company operates independently with its own product lines and services.

Differentiator

Problem solved

Functional benefit

Brands

• ClaimInsight: A Preferred Provider Organization (PPO) enhancement solution providing physician-led medical review and audit of hospital claims, offered through portfolio company AMPS.
• PriceDynamix
• Drexi
• Oasis Ascent

Products and services

• Healthcare Private Equity Investment

Named customers3 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves10 records

Expansion highlights6 records

Broad incumbents

• New Mountain Capital: Large private equity firm with a dedicated healthcare services franchise. A broader incumbent that competes for healthcare services platforms at the upper end of the middle market.
• Genstar Capital: Large middle-market private equity firm where Cimarron founder James Nadauld previously led healthcare services investments for a decade. A scaled incumbent that also invests in healthcare services, providing a relevant broader-market benchmark.
• TPG Capital: Large alternative asset manager with a dedicated healthcare practice spanning services, life sciences, and healthcare technology. A broad incumbent that provides scale and strategic context for the healthcare investing landscape Cimarron operates in.
• Avista Capital Partners: Healthcare-focused middle-market private equity firm. A broader incumbent that overlaps with Cimarron's target healthcare services subsectors at slightly larger deal sizes.
• Welsh, Carson, Anderson & Stowe: Established healthcare-focused private equity firm with a long history of healthcare services and technology investing. A scaled incumbent that also concentrates on healthcare, providing strategic and competitive context for Cimarron.

Direct peers

• Linden Capital Partners: Healthcare-dedicated private equity firm focused on control investments in middle-market healthcare companies. Comparable in its exclusive healthcare focus and mid-market orientation.
• Revelstoke Capital Partners: Healthcare-focused private equity firm that invests in lower-middle market healthcare services and technology companies. Direct comparable on healthcare specialization, buy-and-build strategy, and target company size.
• Cressey & Company: Healthcare-dedicated private equity firm based in Chicago focused on lower-middle market healthcare services and technology businesses. Direct comparable given pure healthcare focus and middle-market orientation.
• Varsity Healthcare Partners: Healthcare-focused private equity firm investing in lower-middle market healthcare companies, with a similar partnership-oriented approach to founder-owned healthcare businesses. Most direct comparable in size, sector focus, and strategy.
• Sheridan Capital Partners: Healthcare-focused private equity firm investing in lower-middle market healthcare services and technology companies. Direct comparable given dedicated healthcare focus and middle-market deal profile.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cimarron-healthcare-capital

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cimarron Healthcare Capital